RT Conference Proceedings
T1 TA-ness classification discriminates RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients (pts) who may benefit from antiEGFR treatment
A1 Santos, C.
A1 Lawrence, P.
A1 Lopez-Doriga, A.
A1 Ragulan, C.
A1 Fontana, E.
A1 Desai, K.
A1 Ps, H.
A1 Elez Fernandez, M. E.
A1 Aranda Aguilar, E.
A1 Losa, F.
A1 Paez, D.
A1 Layos Romero, L.
A1 Sanjuan, X.
A1 Canas, M. A.
A1 Azuara, D.
A1 Queralt, B.
A1 Fernandez-Calotti, P.
A1 Salazar, R.
A1 Sadanandam, A.
PB Elsevier
SN 0923-7534
YR 2021
FD 2021-09-21
LK https://hdl.handle.net/10668/25751
UL https://hdl.handle.net/10668/25751
LA en
DS RISalud
RD Apr 7, 2025